LAVOIE EDMOND J has a total of 28 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BARBOSA JOSEPH, CELGENE CAR LLC and NEUROTHERAPEUTICS PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 11 | |
#3 | Australia | 2 | |
#4 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Lavoie Edmond J | 27 |
#2 | Ruchelman Alexander L | 9 |
#3 | Parhi Ajit | 8 |
#4 | Liu Leroy F | 8 |
#5 | Pilch Daniel S | 6 |
#6 | Rice Joseph E | 5 |
#7 | Zhang Yongzheng | 4 |
#8 | Sun Yangsheng | 3 |
#9 | Liu Leroy Fong | 3 |
#10 | Yuan Yi | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018165614A1 | Bacterial efflux pump inhibitors | |
WO2018165612A1 | Bacterial efflux pump inhibitors | |
WO2011159926A1 | Antimicrobial agents | |
US2012059026A1 | Antimicrobial agents | |
US2009156627A1 | Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA | |
WO2004014906A2 | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents | |
AU2003265406A1 | Nitro and amino substituted topoisomerase agents | |
AU2002352708A1 | Cytotoxic agents |